Mostly Markets
Subscribe
Stocks/Health Care/Health Care Supplies

Cooper CompaniesCOO

Health Care Supplies · San Ramon, California · In the S&P 500
Solid businessCheaper than peers
$59.55−1.31%After hours: $59.25 (−0.50%)At the close, 30 Oct · Prices from CNBC, may be delayed
▼ 14.4% over 1 year
Cooper Companies over 1 yearDaily close, $, to 30 Oct 2026
$70$80Nov2026MarMayJulSep$59.55$80NovMarJul$59.55
Source: Nasdaq daily closes
Market value$11.32B
Price to earnings20.3x
Forward P/E13.1x
Dividend yield–
Year to date−27.3%
One year−14.4%
Next earningsNot scheduled
SectorHealth Care
52-week range (closes)
$53.27$84.32

Quality and valuation

How Cooper Companies compares with other health care stocks. A description, not a recommendation.

Cooper Companies and 5 health care supplies peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: about averageValuation: cheaper than most

An average business among health care companies, priced below most of them.

Cooper Companies trades at 13.1 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew slower than the sector median: +4.7% vs +7.8%
  • Keeps more of each sale (gross margin): 65.9% vs 65.3%
  • Less profitable (operating margin): 12.8% vs 13.3%
  • Turns more of its sales into cash: 16.0% vs 15.9%
COO trades at 13.1x forward earnings, below the sector medianForward p/e, Health Care Supplies peers
COO13.1xNVS17.0xAZN17.5xMRK18.1xUNH18.9xABBV19.6xJNJ25.1xLLY36.3xSector median 19.1xCOO13.1xNVS17.0xAZN17.5xMRK18.1xUNH18.9xABBV19.6xJNJ25.1xLLY36.3xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 20.3x earnings, COO is cheaper than its average since Aug 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
40x60xAverage 42.3x2025202620.3x40x60xAverage 42.3x2025202620.3x
Source: Nasdaq prices; SEC filings

Financials

From Cooper Companies's SEC filings, through the quarter ending 31 Jul 2026. Hover or tap a bar for its value.

Revenue grew 0.6% from a year earlierQuarterly revenue, $bn, latest Q3 ’26
$0.0bn$0.5bn$1.0bnQ4 ’24Q2 ’25Q4 ’25$1.1bnQ3 ’26$0.0bn$0.5bn$1.0bnQ4 ’24Q2 ’25Q4 ’25$1.1bnQ3 ’26
Source: SEC filings
Growth slowed to +0.6% last quarterRevenue growth, year on year, %
0%2%5%8%Q4 ’24Q2 ’25Q4 ’250.6%Q3 ’260%5%Q4 ’24Q2 ’25Q4 ’250.6%Q3 ’26
Source: SEC filings
Operating margin was 20.8% last quarterOperating income as a share of revenue, %
0%10%20%Q4 ’24Q2 ’25Q4 ’2520.8%Q3 ’260%10%20%Q4 ’24Q2 ’25Q4 ’2520.8%Q3 ’26
Source: SEC filings
Free cash flow was $678 million over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $m
$0m$100m$200mQ4 ’24Q2 ’25Q4 ’25$273mQ3 ’26$0m$100m$200mQ4 ’24Q2 ’25Q4 ’25$273mQ3 ’26
Source: SEC filings
Last 12 monthsCOOSector median
Revenue growth+4.7%+7.8%
Gross margin65.9%65.3%
Operating margin12.8%13.3%
Free cash flow margin16.0%15.9%
Price to earnings20.3x30.2x

Stories on Cooper Companies

We haven't written about Cooper Companies yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care Supplies, by market value.

CompanyPriceTodayYTDValue
LLYEli Lilly$1,417.54+3.19%+31.9%$1.33T
JNJJohnson & Johnson$273.20−0.73%+32.0%$658B
ABBVAbbVie$294.89+1.41%+29.1%$521B
MRKMerck$149.52+2.18%+42.0%$369B
UNHUnitedHealth$406.97−0.96%+23.3%$365B
NVSNovartis$160.79−0.19%+16.6%$327B
AZNAstraZeneca$186.65+7.02%+6.4%$290B
TMOThermo Fisher Scientific$697.00−1.72%+20.3%$258B